Immunomodulatory effect of water extract of cinnamon on anti-CD3-induced cytokine responses and p38, JNK, ERK1/2, and STAT4 activation

References

• Tanaka, S., Yoon, Y.H., Fukui, H., Tabata, M., Akira, T., Okano, K., Iwai, M., Iga, Y., Yokoyama, K. Antiulcerogenic compounds isolated from Chinese cinnamon. Planta Med 1989, 55, 245–248.
   PubMedGoogle Scholar
• Matsuda, H., Matsuda, R., Fukuda, S., Shiomoto, H., Kubo, M. Anti-thrombic actions of 70% methanolic extract and cinnamic aldehyde from Cinnamomi Cortex. Chem Pharm Bull 1987, 35, 1275–1280.
   PubMed Web of Science ®Google Scholar
• Zhuang, M., Jiang, H., Suzuki, Y., Li, X., Xiao, P., Tanaka, T., Ling, H., Yang, B., Saitoh, H., Zhang, L., Qin, C., Sugamura, K., Hattori, T. Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS–CoV infection. Antiviral Res 2009, 82, 73–81.
   PubMed Web of Science ®Google Scholar
• Hayashi, K., Imanishi, N., Kashiwayama, Y., Kawano, A., Terasawa, K., Shimada, Y., Ochiai, H. Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antiviral Res 2007, 74, 1–8.
   PubMed Web of Science ®Google Scholar
• Imparl-Radosevich, J., Deas, S., Polansky, M.M., Baedke, D.A., Ingebritsen, T.S., Anderson, R.A., Graves, D.J. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res 1998, 50, 177–182.
   PubMedGoogle Scholar
• Qin, B., Nagasaki, M., Ren, M., Bajotto, G., Oshida, Y., Sato, Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 2003, 62, 139–148.
   PubMed Web of Science ®Google Scholar
• Khan, A., Safdar, M., Ali Khan, M.M., Khattak, K.N., Anderson, R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003, 26, 3215–3218.
   PubMed Web of Science ®Google Scholar
• Cao, H., Polansky, M.M., Anderson, R.A. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 2007, 459, 214–222.
   PubMed Web of Science ®Google Scholar
• Anderson, R.A., Broadhurst, C.L., Polansky, M.M., Schmidt, W.F., Khan, A., Flanagan, V.P., Schoene, N.W., Graves, D.J. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 2004, 52, 65–70.
   PubMed Web of Science ®Google Scholar
• Schroder, K., Hertzog, P.J., Ravasi, T., Hume, D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75, 163–189.
   PubMed Web of Science ®Google Scholar
• Akbar, A.N., Salmon, M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today 1997, 18, 72–76.
   PubMedGoogle Scholar
• Lichtman, A.H., Kurt-Jones, E.A., Abbas, A.K. B-cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc Natl Acad Sci USA 1987, 84, 824–827.
   PubMedGoogle Scholar
• Scott, D.E., Gause, W.C., Finkelman, F.D., Steinberg, A.D. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J Immunol 1990, 145, 2183–2188.
   PubMedGoogle Scholar
• Vella, A., Teague, T.K., Ihle, J., Kappler, J., Marrack, P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 1997, 186, 325–330.
   PubMed Web of Science ®Google Scholar
• Modiano, J.F., Mayor, J., Ball, C., Chitko-McKown, C.G., Sakata, N., Domenico-Hahn, J., Lucas, J.J., Gelfand, E.W. Quantitative and qualitative signals determine T-cell cycle entry and progression. Cell Immunol 1999, 197, 19–29.
   PubMedGoogle Scholar
• Podojil, J.R., Miller, S.D. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy. Immunol Rev 2009, 229, 337–355.
   PubMed Web of Science ®Google Scholar
• Rudd, C.E., Taylor, A., Schneider, H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009, 229, 12–26.
   PubMed Web of Science ®Google Scholar
• Hayden, M.S., Ghosh, S. Signaling to NF-kappaB. Genes Dev 2004, 18, 2195–2224.
   PubMed Web of Science ®Google Scholar
• Weiss, L., Whitmarsh, A.J., Yang, D.D., Rincón, M., Davis, R.J., Flavell, R.A. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation. J Exp Med 2000, 191, 139–146.
   PubMedGoogle Scholar
• Grogan, J.L., Mohrs, M., Harmon, B., Lacy, D.A., Sedat, J.W., Locksley, R.M. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001, 14, 205–215.
   PubMed Web of Science ®Google Scholar
• Monick, M.M., Samavati, L., Butler, N.S., Mohning, M., Powers, L.S., Yarovinsky, T., Spitz, D.R., Hunninghake, G.W. Intracellular thiols contribute to Th2 function via a positive role in IL-4 production. J Immunol 2003, 171, 5107–5115.
   PubMedGoogle Scholar
• DeSilva, D.R., Feeser, W.S., Tancula, E.J., Scherle, P.A. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. J Exp Med 1996, 183, 2017–2023.
   PubMedGoogle Scholar
• Chen, C.Y., Gherzi, R., Andersen, J.S., Gaietta, G., Jürchott, K., Royer, H.D., Mann, M., Karin, M. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000, 14, 1236–1248.
   PubMedGoogle Scholar
• Dong, C., Yang, D.D., Tournier, C., Whitmarsh, A.J., Xu, J., Davis, R.J., Flavell, R.A. JNK is required for effector T-cell function but not for T-cell activation. Nature 2000, 405, 91–94.
   PubMedGoogle Scholar
• Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J., Flavell, R.A. Defective T cell differentiation in the absence of Jnk1. Science 1998, 282, 2092–2095.
   PubMed Web of Science ®Google Scholar
• Berenson, L.S., Yang, J., Sleckman, B.P., Murphy, T.L., Murphy, K.M. Selective requirement of p38alpha MAPK in cytokine-dependent, but not antigen receptor-dependent, Th1 responses. J Immunol 2006, 176, 4616–4621.
   PubMedGoogle Scholar
• Rincón, M., Enslen, H., Raingeaud, J., Recht, M., Zapton, T., Su, M.S., Penix, L.A., Davis, R.J., Flavell, R.A. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998, 17, 2817–2829.
   PubMed Web of Science ®Google Scholar
• Guo, L., Urban, J.F., Zhu, J., Paul, W.E. Elevating calcium in Th2 cells activates multiple pathways to induce IL-4 transcription and mRNA stabilization. J Immunol 2008, 181, 3984–3993.
   PubMedGoogle Scholar
• Takeda, K., Harada, Y., Watanabe, R., Inutake, Y., Ogawa, S., Onuki, K., Kagaya, S., Tanabe, K., Kishimoto, H., Abe, R. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis. Int Immunol 2008, 20, 1507–1515.
   PubMedGoogle Scholar
• Sanchez-Lockhart, M., Miller, J. Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription. J Immunol 2006, 176, 4778–4784.
   PubMed Web of Science ®Google Scholar
• Koh, W.S., Yoon, S.Y., Kwon, B.M., Jeong, T.C., Nam, K.S., Han, M.Y. Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation. Int J Immunopharmacol 1998, 20, 643–660.
   PubMed Web of Science ®Google Scholar
• Pacifico, L., Di Renzo, L., Anania, C., Osborn, J.F., Ippoliti, F., Schiavo, E., Chiesa, C. Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 2006, 154, 691–697.
   PubMed Web of Science ®Google Scholar
• Rocha, V.Z., Folco, E.J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A.H., Libby, P. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008, 103, 467–476.
   PubMed Web of Science ®Google Scholar